共 195 条
[1]
Burstein HJ(2021)Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 Ann. Oncol. 32 1216-1235
[2]
Curigliano G(2018)Differences in breast cancer survival by molecular subtypes in the United States Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 27 619-626
[3]
Thürlimann B(1997)Apoptosis and the dilemma of cancer chemotherapy Blood 89 1845-1853
[4]
Weber WP(2013)Decoding and unlocking the BCL-2 dependency of cancer cells Nat. Rev. Cancer 13 455-465
[5]
Poortmans P(2008)Bcl-2 family proteins and cancer Oncogene 27 6398-6406
[6]
Regan MM(2015)Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer Cell Death Differ. 22 2098-2106
[7]
Howlader N(1997)Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases Cancer J. Sci. Am. 3 230-237
[8]
Cronin KA(2013)A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells Cancer Cell 24 182-196
[9]
Kurian AW(2015)The BCL-2 protein family, BH3-mimetics and cancer therapy Cell Death Differ. 22 1071-1080
[10]
Andridge R(2012)Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death Int. J. Mol. Sci. 13 9545-9571